HIV-2 gp32

HIV-2 gp32 Recombinant
Cat. No.
BT24008
Source
Escherichia Coli.
Synonyms
Appearance
Sterile filtered colorless clear solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

HIV-2 gp32 recombinant- contains the full-length sequence of HIV-2 envelope immunodominant regions gp32. The protein is fused with b-galactosidase (114 kDa) at N-terminus.

Product Specs

Introduction
HIV-1 and HIV-2 exhibit distinct RNA packaging mechanisms. HIV-1 demonstrates non-specific RNA binding, while HIV-2 preferentially packages its own Gag protein mRNA. This difference contributes to the higher mutation rate observed in HIV-1. Transmission routes for HIV-2 mirror those of HIV-1, encompassing exposure to infected bodily fluids such as blood, semen, tears, and vaginal secretions. Notably, HIV-2 infection is characterized by a slower progression to immunodeficiency, reduced infectivity during initial stages, and increased infectivity as the disease advances. Key distinctions between the two viruses include HIV-2's lower pathogenicity compared to HIV-1, enhanced immune control in HIV-2 infection, and a degree of CD4 independence. Despite significant sequence and phenotypic variations, the envelope structures of HIV-1 and HIV-2 share similarities. Both membrane-anchored proteins assemble into six-helix bundles, a common feature in viral and cellular fusion proteins, which is believed to drive the fusion process. Interestingly, while HIV-1 gp41 helical regions form more stable six-helix bundles, HIV-2 fusion occurs at a lower temperature (25°C), exhibits independence from calcium ions, remains unaffected by cytochalasin B treatment on target cells, and demonstrates insensitivity to target membrane glycosphingolipid composition.
Description
Recombinant HIV-2 gp32 encompasses the complete amino acid sequence of the immunodominant gp32 region of the HIV-2 envelope. The protein is expressed as a fusion protein with b-galactosidase (114 kDa) at its N-terminus.
Physical Appearance
The product appears as a clear, colorless solution that has been sterilized through filtration.
Formulation
The HIV-2 gp32 is provided in a solution containing 1mg/ml of the protein in a buffer composed of 0.01M Na2CO3, 0.01M Na3EDTA, 0.014 M b-mercaptoethanol, and 0.02% Sarcosyl.
Purity
The purity of the HIV-2 gp32 protein is determined to be greater than 95% using SDS-PAGE analysis.
Stability
To maintain protein stability, store at 4°C upon receipt. Avoid freezing.
Applications
HIV-2 gp32 antigen serves as a valuable reagent in various immunological assays. Its applications include utilization in enzyme-linked immunosorbent assays (ELISA) and Western blots. Moreover, it exhibits excellent efficacy as an antigen for the early detection of HIV seroconvertors, demonstrating minimal specificity issues.
Source
Escherichia Coli.
Specificity
Immunoreactive with all sera of HIV-2 infected individuals.

Product Science Overview

Introduction

HIV-2 gp32 is a recombinant protein derived from the Human Immunodeficiency Virus type 2 (HIV-2). This protein is a part of the envelope glycoprotein complex of the virus, which plays a crucial role in the virus’s ability to infect host cells. The recombinant form of HIV-2 gp32 is produced using genetic engineering techniques, typically involving the expression of the protein in a host organism such as Escherichia coli .

Structure and Composition

The HIV-2 gp32 recombinant protein contains the full-length sequence of the immunodominant regions of the HIV-2 envelope glycoprotein gp32. It is often fused with beta-galactosidase at the N-terminus, resulting in a protein with a molecular weight of approximately 114 kDa . The protein is typically formulated in a sterile, filtered, colorless, clear solution containing various stabilizing agents .

Function and Role in HIV-2

The gp32 protein is a critical component of the HIV-2 envelope, which facilitates the virus’s entry into host cells. It is involved in the fusion of the viral membrane with the host cell membrane, a process essential for the virus to deliver its genetic material into the host cell . The recombinant form of gp32 retains the immunodominant regions of the native protein, making it useful for various research and diagnostic applications.

Applications

HIV-2 gp32 recombinant protein is widely used in research and diagnostic settings. It is particularly valuable in enzyme-linked immunosorbent assays (ELISA) and Western blot assays for the detection of HIV-2 antibodies in patient sera . The protein’s immunoreactivity with sera from HIV-2 infected individuals makes it an excellent antigen for early detection of HIV seroconverters with minimal specificity problems .

Production and Purity

The recombinant HIV-2 gp32 protein is produced in Escherichia coli and purified to a high degree of purity, typically greater than 95% as determined by SDS-PAGE . The protein is formulated in a solution containing sodium carbonate, sodium EDTA, beta-mercaptoethanol, and sarcosyl to ensure stability and maintain its functional integrity .

Storage and Stability

The HIV-2 gp32 recombinant protein should be stored at 4°C upon arrival and should not be frozen to maintain its stability and functionality . Proper storage conditions are essential to preserve the protein’s immunoreactivity and overall quality.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.